Evidence-based Guidance has been developed to define optimal service models to ensure that patients with cancer, their families and other carers receive high quality support to help them to cope with cancer and its treatment.

Before commissioners and Trusts can implement this Guidance, they need to assess the cost implications of the recommendations. This report sets out this information.